Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience

[1]  A. Fischer,et al.  AIRE deficiency in thymus of 2 patients with Omenn syndrome. , 2005, The Journal of clinical investigation.

[2]  Gabriele Rossi,et al.  Non‐myeloablative stem cell transplantation for severe combined immunodeficiency – Omenn syndrome , 2004, British journal of haematology.

[3]  J. Li,et al.  Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. , 2004, The Journal of allergy and clinical immunology.

[4]  L. Notarangelo,et al.  Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. , 2003, Immunology letters.

[5]  R. Miniero,et al.  Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome , 2003, Bone Marrow Transplantation.

[6]  A. Fischer,et al.  Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. , 2002, Blood.

[7]  J. Puck,et al.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. , 2002, Blood.

[8]  P. Jeggo,et al.  DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. , 2001, Molecular cell.

[9]  A. Fischer,et al.  Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. , 2001, Blood.

[10]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.

[11]  E. Mazzolari,et al.  Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. , 2000, Haematologica.

[12]  F. Rieux-Laucat,et al.  Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. , 1998, The Journal of clinical investigation.

[13]  Sandro Santagata,et al.  Partial V(D)J Recombination Activity Leads to Omenn Syndrome , 1998, Cell.

[14]  L. Notarangelo,et al.  In vitro cell death of activated lymphocytes in Omenn's syndrome , 1997, European journal of immunology.

[15]  R. Shapiro,et al.  Mismatched bone marrow transplantation for Omenn syndrome: a variant of severe combined immunodeficiency. , 1995, Bone marrow transplantation.

[16]  J. Arbiser,et al.  Genetic immunodeficiencies: cutaneous manifestations and recent progress. , 1995, Journal of the American Academy of Dermatology.

[17]  A. Fischer,et al.  Treatment of Omenn syndrome by bone marrow transplantation. , 1995, The Journal of pediatrics.

[18]  A. Fischer,et al.  Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. , 1993, The Journal of pediatrics.

[19]  R. Levinsky,et al.  Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency. , 1988, Pediatrics.

[20]  R. Gatti,et al.  Immunological reconstitution of sex-linked lymphopenic immunological deficiency. , 1968, Lancet.

[21]  J. Bach,et al.  In vitro Detection of Immunosuppressive Activity of Anti-lymphocyte Sera , 1968, Nature.

[22]  G. Omenn.  FAMILIAL RETICULOENDOTHELIOSIS WITH EOSINOPHILIA. , 1965, The New England journal of medicine.